Brendan Smith
Stock Analyst at TD Cowen
(1.14)
# 3,708
Out of 5,182 analysts
16
Total ratings
36.36%
Success rate
-4.68%
Average return
Main Sectors:
Stocks Rated by Brendan Smith
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DNA Ginkgo Bioworks Holdings | Maintains: Buy | $14 → $12 | $6.90 | +73.91% | 2 | Jan 8, 2026 | |
| TWST Twist Bioscience | Maintains: Buy | $32 → $43 | $50.21 | -14.36% | 1 | Jan 8, 2026 | |
| SLP Simulations Plus | Maintains: Hold | $16 → $19 | $11.99 | +58.47% | 2 | Jan 8, 2026 | |
| SDGR Schrödinger | Maintains: Buy | $33 → $24 | $11.58 | +107.25% | 1 | Jan 8, 2026 | |
| CTKB Cytek Biosciences | Maintains: Buy | $4 → $5 | $4.53 | +10.38% | 1 | Jan 8, 2026 | |
| AZTA Azenta | Maintains: Hold | $35 → $39 | $22.63 | +72.34% | 1 | Jan 8, 2026 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $79 → $90 | $64.49 | +39.56% | 3 | Jan 8, 2026 | |
| NVAX Novavax | Maintains: Hold | $8 → $7 | $7.70 | -9.09% | 2 | Nov 4, 2025 | |
| WST West Pharmaceutical Services | Initiates: Buy | $350 | $254.80 | +37.36% | 1 | Oct 29, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Outperform | n/a | $61.03 | - | 1 | Jul 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $20.65 | - | 1 | Dec 5, 2022 |
Ginkgo Bioworks Holdings
Jan 8, 2026
Maintains: Buy
Price Target: $14 → $12
Current: $6.90
Upside: +73.91%
Twist Bioscience
Jan 8, 2026
Maintains: Buy
Price Target: $32 → $43
Current: $50.21
Upside: -14.36%
Simulations Plus
Jan 8, 2026
Maintains: Hold
Price Target: $16 → $19
Current: $11.99
Upside: +58.47%
Schrödinger
Jan 8, 2026
Maintains: Buy
Price Target: $33 → $24
Current: $11.58
Upside: +107.25%
Cytek Biosciences
Jan 8, 2026
Maintains: Buy
Price Target: $4 → $5
Current: $4.53
Upside: +10.38%
Azenta
Jan 8, 2026
Maintains: Hold
Price Target: $35 → $39
Current: $22.63
Upside: +72.34%
Halozyme Therapeutics
Jan 8, 2026
Maintains: Buy
Price Target: $79 → $90
Current: $64.49
Upside: +39.56%
Novavax
Nov 4, 2025
Maintains: Hold
Price Target: $8 → $7
Current: $7.70
Upside: -9.09%
West Pharmaceutical Services
Oct 29, 2025
Initiates: Buy
Price Target: $350
Current: $254.80
Upside: +37.36%
Arrowhead Pharmaceuticals
Jul 21, 2023
Initiates: Outperform
Price Target: n/a
Current: $61.03
Upside: -
Dec 5, 2022
Initiates: Outperform
Price Target: n/a
Current: $20.65
Upside: -